Day: October 13, 2021

BEIJING, Oct. 13, 2021 /PRNewswire/ — Respecting and taking care of the elders, specifically one’s parents, is regarded as a legacy through China’s 5,000 years of civilization. The concept of filial piety goes back to 400 BC when it was mentioned in the early works by renowned ancient philosophers.

Chongyang, or Double Ninth Festival, is celebrated on the 9th day of the ninth month on lunar Chinese calendar, which falls on October 14 this year. It has long been a day for Chinese to show care and love to the elderly.

Busy working children would spend the day at home catching up with older relatives, with Chinese President Xi Jinping leading the way.

Xi, the filial son

Despite a tight schedule, Xi would take a walk with his mother, holding her hands, whenever he has time.

According to CMG, there are two photos on his bookshelf: one of him taking a walk alongside his father in a wheelchair and other family members, and another of him walking with his mother.

Deference to seniors has become one of Xi’s traits, not just to the elderly in his family, but the entire society at large.

Xi calls for respect for veterans

Back in 1984, Xi, then secretary of the Zhengding County Committee of the Communist Party of China (CPC) in north China’s Hebei Province, wrote in an article that “young and middle-aged officials should respect the veterans in building a sincere relationship of cooperation, and thus work side by side and push forward the work of the Party.”

At that time, he called for more care for seniors. He emptied a meeting room and changed it to a recreation space for the elderly. In addition, he prioritized their hospitalization and solved many difficulties for seniors.

Throughout his political career, the Chinese president has always championed the cause of elderly care. Moments demonstrating his care and respect for the elderly are quite popular.

Since the 18th CPC National Congress in 2012, Xi has given a series of instructions and adopted relevant plans and arrangements to develop the country’s elderly-care services and the pension system.

During his domestic inspections, Xi would regularly visit elderly care facilities to check if support policies have been well implemented and the residents are given proper care.

The development of an aged care system was included in the 13th Five-Year Plan and received 13.4 billion yuan (nearly $2 billion) from the central budget between 2015 and 2020.

During the 14th Five-Year Plan (2021-2025), China will further improve the infrastructure that helps support elderly care services and improve their quality. According to the plan, the country’s basic old-age insurance coverage will reach 95 percent by 2025, up from 90 percent in 2020.

According to the newly released China’s seventh population census, the country has 264 million people aged 60 and above and 191 million aged 65 and above, comprising 18.7 percent and 13.5 percent of the total population, respectively.

https://news.cgtn.com/news/2021-10-13/-Chongyang-Festival-The-Chinese-legacy-of-filial-piety-14k7hkl3tS0/index.html

BAODING, China, Oct. 13, 2021 /PRNewswire/ — Aiming for carbon neutrality, GWM recently released several hybrid electric vehicles that showed its latest R&D results in hybrid technology in order to promote the R&D of hybrid technology and the upgrading of models.

The Hybrid technology is an essential part of the overall strategic plan of GWM. Motivated by the R&D concept of “large-investment”, GWM has independently designed and developed the L.E.M.O.N. platform through five-year efforts, investing RMB 20 billion. This platform can be adapted to two different hybrid architectures, namely Dedicated Hybrid Technology (DHT) architecture and P2/P2+P4 architecture.

The L.E.M.O.N. DHT, a highly integrated petrol-electric hybrid technology, can achieve optimum performance in all speed ranges and all scenarios through coordination between efficient hybrid engine and the dual-motor hybrid system to bring users fast, smooth, quiet and economical driving experiences.

HAVAL H6 HEV, which made its global debut in Thailand in June, was equipped with this technology. Once released, it stirred the local new energy vehicle market and was favoured by local users. Its market sales ranked No.1 in the market segment of Thailand in a short time.

This technology was also adopted by WEY MAQIDUO(Chinese name), which was launched at Tianjin International Auto Show on September 29, 2021. This new model was capable of fast power response, strong acceleration capability, smooth gear shifting, and quiet and comfortable driving in various scenarios. Because of using a high-power and large-capacity HEV battery, it is quite fuel-efficient with a total driving range of up to 1,100 km and comprehensive fuel consumption of only 4.7 L/100 km.

Additionally, WEY Coffee 01 PHEV adopts a hybrid architecture of P2+P4. The vehicle appeared at the International Automobil-Ausstellung (IAA) held in Munich on September 6, 2021. This drive motor is respectively installed on the front and rear axles to rival the electric four-wheel drive system without the driveshaft. This combination features strong power, sound economic efficiency while being applied in multiple scenarios, diversified driving modes and flexibility. This brings plug-in hybrid power suitable for multiple scenarios to Coffee 01 PHEV, supporting an acceleration capability of 5s/100km and a maximum speed of 235 km/h.

Currently, models equipped with the L.E.M.O.N. hybrid technology have covered two major brands, namely HAVAL and WEY. Then, more hybrid electric vehicles will be launched later to continuously provide a clean and efficient driving experience for global users.

Also, GWM insists on multiple technology routes including hybrid, pure electric and hydrogen energy as well as possessing several technical reserves such as cobalt-free batteries and Dayu batteries, making a comprehensive technical plan in clean energy.

As Jack Wei, Chairman of GWM, said at the 2025 Strategy Conference, in the next five years, GWM would expect to invest up to a total of RMB 100 billion in R&D, especially in pure electric, hydrogen energy and hybrid technologies, to maintain its technical leading position.

Photo – https://mma.prnewswire.com/media/1659376/1.jpg

GUANGZHOU, China, Oct. 13, 2021 /PRNewswire/ — The GA8, GN8 and GN6 have officially been approved for use in public transport by the Roads and Transport Authority (RTA) of the United Arab Emirates. Of the three models approved, the GA8 has been approved for use as a luxury vehicle in the realm of public transport; the GN8 and GN6 have been approved for use as taxi vehicles in the realm of transport.

This development is a monumental step for GAC MOTOR in the region, demonstrating that governing bodies of the UAE officially endorse GAC MOTOR as a brand of national-level quality and reliability.

The RTA of the UAE imposes strict guidelines on the vehicles approved for public transport, to ensure that the roads remain safe. RTA approval is granted only to companies that satisfy rigorous quality standards.

Gaining RTA approval in the UAE is a huge leap forward and a testament to the superior quality of the GA8, GN8 & GN6 as cutting-edge passenger vehicles, significantly bolstering the brand reputation behind the GAC MOTOR logo.

RTA approval for these three models also opens up a new and exciting channel for sales in the Middle East region. Whether it’s the executive sedan GA8 taking stylish passengers around the city center,  or the larger GN8 and GN6 picking up VIP passengers from the airport in style, more and more GAC MOTOR vehicles will appear on the road, and be able to improve the mobile lives of UAE citizens and visitors.

This increased visibility will add greatly to GAC MOTOR’s brand image, and help add to the company’s reputation as a reliable and worthy new arrival on the international automotive scene.

This is the first time that GAC MOTOR has been selected to serve as a public taxi in an overseas market.

Since entering the UAE market in 2015, being approved for public transport has been one of many goals for GAC MOTOR. With the completion of this step, the future looks bright for a many more achievements in the long and healthy development of the UAE market.

This is just the beginning. GAC MOTOR looks forward to bringing more and more outstanding vehicles to overseas markets, satisfying global consumer demand with groundbreaking technology and cutting-edge Chinese vehicle craftsmanship.

Let’s go.

Photo – https://mma.prnewswire.com/media/1659325/image_5011064_40515019.jpg

• The vaccine is more than 75% effective among subjects under the age of 60. Sputnik Light also provides much higher efficacy against severe disease and hospitalizations.
• Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decline in efficacy against the Delta variant to less than 50% five months after injection.
• An article with efficacy analysis of vaccination with the one-shot Sputnik Light vaccine against the Delta variant has been submitted to the medRxiv website for publication this week.
• The two-shot Sputnik V vaccine is authorized in 70 countries, with populations totaling over 4 billion people.
• The one-shot Sputnik Light vaccine is authorized in more than 15 countries, with ongoing registration processes in another 30 countries.
• Sputnik Light is a universal booster for other vaccines: positive data from clinical studies in Argentina and other countries demonstrate high safety and immunogenicity of Sputnik Light administered as a booster shot for vaccines of other producers.
• Efficacy of the one-shot Sputnik Light vaccine as a booster against the Delta variant for other vaccines will be close to the efficacy against Delta variant of the Sputnik V vaccine: over 83% against infection and over 94% against hospitalization.

MOSCOW, Oct. 13, 2021 /PRNewswire/ — The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Gamaleya National Research Center of Epidemiology and Microbiology today announced the results of an efficacy analysis of the one-shot Sputnik Light vaccine against infection from the Delta variant of coronavirus.

Gamaleya Center has submitted an article analyzing efficacy of Sputnik Light vaccine against the Delta variant to the medRxiv preprint server for health sciences for publication this week.

I. Efficacy of Sputnik Light as a standalone vaccine

The article states that the Sputnik Light vaccine administered alone has demonstrated 70% efficacy against infection from the Delta variant of coronavirus during the first three months after vaccination. The vaccine is 75% effective among subjects under the age of 60. Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decline in efficacy against the Delta variant to less than 50% five months after injection.

Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations.

The analysis was conducted based on data from 28,000 participants who had received a single dose of Sputnik Light, compared with a control group of 5.6 million individuals who were not vaccinated. The data used in the study was collected in July 2021 in Moscow.

II. Efficacy of Sputnik Light as a booster shot

A one-shot vaccination regimen of Sputnik Light has a number of key advantages, including ease of administering the vaccine, monitoring and more flexible re-vaccination schedule when used as a booster.

Efficacy of one-shot Sputnik Light as a booster against Delta variant for other vaccines will be close to the efficacy against the Delta variant of the Sputnik V vaccine: over 83% against infection and over 94% against hospitalization.

III. Real-world data on Sputnik Light and studies of combination with other vaccines

The Sputnik Light vaccine is based on the human adenovirus serotype 26, the first component of Sputnik V – the world’s first registered vaccine against coronavirus. Sputnik Light has been authorized in more than 15 countries with the registration process ongoing in a further 30 countries. Sputnik Light will be produced by RDIF’s international partners in more than 10 countries (India, China, South Korea, Vietnam, Mexico, Argentina, Serbia, Turkey, etc.). This includes the Serum Institute of India, the world’s largest vaccine producer.

Sputnik Light has been proven to be safe and highly effective by real-world vaccination data in a number of countries. In particular, the vaccine has demonstrated efficacy of between 78.6-83.7% among the elderly as confirmed by the Ministry of Health of Buenos Aires, Argentina. Paraguay’s Ministry of Health also found Sputnik Light to be 93.5% effective during the country’s ongoing vaccination campaign.

Thanks to its safety and efficacy, the one-shot Sputnik Light vaccine is now used both on a standalone basis and studied in combination with vaccines from other producers in multiple countries.

The heterogeneous boosting approach (a “vaccine cocktail” using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component) was at the core of Sputnik V. This approach was proven to be successful in creating a longer and more durable immunity against coronavirus. RDIF initiated partnerships with other vaccine producers to conduct joint studies on the combination of the first component of Sputnik V with other vaccines.

Such studies are currently ongoing in Russia, Argentina, Azerbaijan and UAE, among others.

In particular, RDIF, Ministry of Health of Argentina, Ministry of Science of Argentina and CONICET are conducting a study to evaluate the immune response and safety of heterogeneous regimens combining Sputnik Light and vaccines produced by AstraZeneca, Sinopharm and Moderna in the city and province of Buenos Aires, as well as the San Luis, Cordoba and La Rioja provinces. Initial results of the study confirm a high safety profile of combinations with no serious adverse events related to vaccination.

Preliminary results of the combined use of the AstraZeneca vaccine and Sputnik Light from a clinical trial in Azerbaijan demonstrated that antibodies to the SARS-CoV-2 virus spike protein (S-protein) elicited in 100% of volunteers. The combined use of the vaccines also shows a high safety profile with no serious adverse events or cases of coronavirus infection after vaccination.

Denis Logunov, Gamaleya Center Deputy Director, commented:

“The Delta variant of coronavirus is one of the most common and dangerous strains. The data analysis presented in the article by the Gamaleya Center demonstrates that Sputnik Light remains highly effective months after vaccination. The results obtained during the study significantly exceed those of some other vaccines, as previously published in scientific media.

“The vaccine’s one-shot regimen makes it is a strong solution for countries with low vaccination rates. Sputnik Light can also be successfully used to maintain existing herd immunity as a booster shot.”

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said:

“The efficacy results of the one-shot Sputnik Light vaccine against the Delta variant of coronavirus significantly outperform those of a number of two-shot vaccines. Crucially, the data from the Gamaleya Center confirms that the one-shot Sputnik Light vaccine is among the best vaccines against coronavirus. This has also been confirmed by a number of other studies.

“Sputnik Light is safe and highly effective when used both on a standalone basis and when combined with other vaccines. The vaccine provides flexibility in immunising the population, contributing to the formation of primary immunity and effective re-vaccination for recipients who originally received a different vaccine. Taking into account its high safety and efficiency, Sputnik Light can become the best universal booster shot globally.

“RDIF actively supports research into combinations of Sputnik Light with other vaccines and has also invited independent international researchers and scientific institutions to cooperate on real-world studies of safety and efficacy of coronavirus vaccines.”